Precision BioSciences (NASDAQ: DTIL) has received FDA Orphan Drug Designations for its nuclease treatments targeting Duchenne muscular dystrophy. The designations ...

Investing.com -- Freddie Mac (OTCQB:OTC: FMCC) reported Thursday that the 30-year fixed-rate mortgage (FRM) averaged 6.75%, a slight increase from last week’s average of 6.72%. The 15-year fixed-rate ...

The Bank of England has requested some lenders to test their ability to withstand potential U.S. dollar shocks, according to ...

Investing.com -- Deutsche Bank resumed coverage on payments and IT services stocks, with preference for high-quality fintech ...

While a downgrade is unlikely given the positive outlook, Moody’s could affirm the Ba3 rating with a stable outlook if debt-to-EBITDA exceeds 4.5x, pre-tax income margin remains below 5.0%, large long ...

Investing.com -- UBS sees limited near-term upside for Renault (EPA: RENA) shares following the automaker’s first profit ...

Investing.com --Macquarie downgraded Seven & i Holdings to Neutral from Outperform after Alimentation Couche-Tard withdrew its takeover bid, removing a key catalyst for the stock and shifting focus ...

Investing.com -- Japan and the European Union are planning to consider joint public-private partnerships as part of efforts to reduce their dependence on China for critical resources like rare earths, ...

Enovis Corp (NYSE: ENOV) stock fell 1.3% after Jehoshaphat Research announced it has taken a short position in the healthcare company, citing concerns about organ ...

Investing.com -- Morgan Stanley identified Bristol-Myers Squibb (NYSE: BMY) as a catalyst-driven idea ahead of a key data ...

Investing.com -- Tobacco stocks showed mixed movements Thursday after the Wall Street Journal reported that the Food and Drug Administration (FDA) has authorized Juul Labs’ e-cigarettes to remain on ...

“Like a butterfly emerging from a chrysalis, we see Oracle transitioning into a new paradigm,” Scotiabank (TSX: BNS) analysts wrote, adding that Oracle is positioning itself as the “Tier-1 independent ...